Form 8-K - Current report:
SEC Accession No. 0001100682-21-000028
Filing Date
2021-12-27
Accepted
2021-12-27 16:42:34
Documents
15
Period of Report
2021-12-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crl-20211222.htm   iXBRL 8-K 35405
2 EX-10.1 exhibit101-8xkfiled122721.htm EX-10.1 39145
3 EX-10.2 exhibit102-8xkfiled122721.htm EX-10.2 51275
7 image_0a.jpg GRAPHIC 6002
  Complete submission text file 0001100682-21-000028.txt   290676

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20211222.xsd EX-101.SCH 1897
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20211222_lab.xml EX-101.LAB 24132
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20211222_pre.xml EX-101.PRE 12509
9 EXTRACTED XBRL INSTANCE DOCUMENT crl-20211222_htm.xml XML 10826
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 211521057
SIC: 8731 Services-Commercial Physical & Biological Research